BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35117033)

  • 1. HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatin.
    Sun J; Qian X; Zhang F; Tang X; Ju C; Liu R; Zhou R; Zhang Z; Lv XB; Zhang C; Huang G
    Transl Cancer Res; 2019 Dec; 8(8):2759-2768. PubMed ID: 35117033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HDAC6 inhibitor WT161 performs anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU.
    Sun J; Wu W; Tang X; Zhang F; Ju C; Liu R; Liang Y; Yu B; Lv B; Guo Y; Zeng D; Tao X; Wang M; Zhang Z; Zhang C; Lv XB
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33860796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the 'garbage-bin' to fight cancer: HDAC6 inhibitor WT161 has an anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU.
    Sergi CM
    Biosci Rep; 2021 Aug; 41(8):. PubMed ID: 34323266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer.
    Hideshima T; Mazitschek R; Qi J; Mimura N; Tseng JC; Kung AL; Bradner JE; Anderson KC
    Oncotarget; 2017 Oct; 8(46):80109-80123. PubMed ID: 29113288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of selective small-molecule HDAC6 inhibitor for overcoming proteasome inhibitor resistance in multiple myeloma.
    Hideshima T; Qi J; Paranal RM; Tang W; Greenberg E; West N; Colling ME; Estiu G; Mazitschek R; Perry JA; Ohguchi H; Cottini F; Mimura N; Görgün G; Tai YT; Richardson PG; Carrasco RD; Wiest O; Schreiber SL; Anderson KC; Bradner JE
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13162-13167. PubMed ID: 27799547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Methylquinazoline derivative 23BB as a highly selective histone deacetylase 6 inhibitor alleviated cisplatin-induced acute kidney injury.
    Hao Y; Guo F; Huang Z; Feng Y; Xia Z; Liu J; Li L; Huang R; Lin L; Ma L; Fu P
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of histone deacetylase inhibitor trichostatin A combined with cisplatin on apoptosis of A549 cell line.
    Zhang X; Jiang SJ; Shang B; Jiang HJ
    Thorac Cancer; 2015 Mar; 6(2):202-8. PubMed ID: 26273359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of sodium butyrate on acetylation of histone in gamma-globin gene promoter regions in K562 cells: a study using chromatin immunoprecipitation].
    Chen JF; Qian XH; Zhao DH; Qian XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1222-5. PubMed ID: 20584642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suberoylanilide hydroxamic acid upregulates histone acetylation and activates endoplasmic reticulum stress to induce apoptosis in HepG2 liver cancer cells.
    Yu L; Xie R; Tian T; Zheng L; Tang L; Cai S; Ma Z; Yang T; Han B; Yang Q
    Oncol Lett; 2019 Oct; 18(4):3537-3544. PubMed ID: 31516571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.
    Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H
    Oncology; 2004; 66(6):481-91. PubMed ID: 15452378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes.
    Choi SY; Ryu Y; Kee HJ; Cho SN; Kim GR; Cho JY; Kim HS; Kim IK; Jeong MH
    Vascul Pharmacol; 2015 Sep; 72():130-40. PubMed ID: 25921924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
    Karasawa Y; Okisaka S
    Jpn J Ophthalmol; 2004; 48(6):542-51. PubMed ID: 15592778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class I and class II histone deacetylases are potential therapeutic targets for treating pancreatic cancer.
    Wang G; He J; Zhao J; Yun W; Xie C; Taub JW; Azmi A; Mohammad RM; Dong Y; Kong W; Guo Y; Ge Y
    PLoS One; 2012; 7(12):e52095. PubMed ID: 23251689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depletion of HDAC6 enhances cisplatin-induced DNA damage and apoptosis in non-small cell lung cancer cells.
    Wang L; Xiang S; Williams KA; Dong H; Bai W; Nicosia SV; Khochbin S; Bepler G; Zhang X
    PLoS One; 2012; 7(9):e44265. PubMed ID: 22957056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.
    Ghoshal K; Datta J; Majumder S; Bai S; Dong X; Parthun M; Jacob ST
    Mol Cell Biol; 2002 Dec; 22(23):8302-19. PubMed ID: 12417732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis by Eleutherine bulbosa (Mill.) Urb. bulb extracted under optimised extraction condition on human retinoblastoma cancer cells (WERI-Rb-1).
    Kamarudin AA; Sayuti NH; Saad N; Razak NAA; Esa NM
    J Ethnopharmacol; 2022 Feb; 284():114770. PubMed ID: 34688803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro.
    Poulaki V; Mitsiades CS; Kotoula V; Negri J; McMillin D; Miller JW; Mitsiades N
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4706-19. PubMed ID: 17898295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced lncRNA ANRIL promotes cisplatin resistance in retinoblastoma cells through regulating ABCG2 expression.
    Yin X; Liao Y; Xiong W; Zhang Y; Zhou Y; Yang Y
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1049-1057. PubMed ID: 32173903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of WT161 as a Potent Agent for the Treatment of Colitis by Targeting the Nucleotide-Binding Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome.
    Long X; Yu X; Gong P; Wang X; Tian L
    Front Pharmacol; 2022; 13():780179. PubMed ID: 35330829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sinomenine Can Inhibit the Growth and Invasion Ability of Retinoblastoma Cell through Regulating PI3K/AKT Signaling Pathway.
    Zheng Q; Zhu Q; Li C; Hao S; Li J; Yu X; Qi D; Pan Y
    Biol Pharm Bull; 2020 Oct; 43(10):1551-1555. PubMed ID: 32759601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.